Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Pentachlorophenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA6 | P23280 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentachlorophenol SCHEMBL8620218 | 0.98 | CYP1A2 (0.44) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL2398810 | 0.98 | CYP1A2 (0.44) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL963480 | 0.88 | CA12 (0.50) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL20484423 | 0.86 | CYP1A2 (0.48) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL1528129 | 0.86 | CYP1A2 (0.48) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL5378694 | 0.86 | CYP1A2 (0.48) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Pentachlorophenol SCHEMBL1990677 | 0.83 | CYP1A2 (0.40) | CYP1A2CYP2C9TSHRCYP2C19HIF1A | |
| Acetic Acid SCHEMBL863599 | 0.81 | CA12 (0.59) | CYP1A2CYP2C9TSHRCYP2C19PAOX | |
| Acetic Acid SCHEMBL3657736 | 0.81 | CA12 (0.59) | CYP1A2CYP2C9TSHRCYP2C19PAOX | |
| Acetic Acid SCHEMBL18288 | 0.81 | CA12 (0.59) | CYP1A2CYP2C9TSHRCYP2C19PAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3083703-B1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DUPONT NUTRITION BIOSCI APS (DK) | 2022-08-10 | — | — | EP | claimed |
| EP-2788194-B1 | HOT MELT CLEANING COMPOSITION, METHOD FOR PREPARING A HOT MELT CLEANING COMPOSITION AND USE THEREOF | OCE TECH BV (NL) | 2019-10-02 | — | — | EP | claimed |
| US-20180345216-A1 | FLUID FOR CARRYING OUT POLLUTION CONTROL IN HEAT ENGINES, AND METHODS FOR PREPARING SAID FLUIDS BY PRODUCING A HOMOGENEOUS SOLUTION | IFP Energies Nouvelles (FR) | 2018-12-06 | — | — | US | claimed |
| EP-3083703-A1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DuPont Nutrition Biosciences ApS (DK) | 2016-10-26 | — | — | EP | claimed |
| WO-2015091629-A1 | PROCESS FOR EXTRACTION OF CALCIUM SENSITIVE PECTIN | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2015-06-25 | — | — | WO | claimed |
| US-20130231302-A1 | ANTIMICROBIAL SOLUTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-09-05 | — | — | US | claimed |
| WO-2012125894-A2 | OXIDATION INHIBITORS FOR AMINE DEGRADATION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-09-20 | — | — | WO | claimed |
| WO-2012034032-A2 | ANTIMICROBIAL SOLUTIONS | THE BOARD OF REGENTS OF UNBIVERSITY OF TEXAS SYSTEM (US) | 2012-03-15 | — | — | WO | claimed |
| US-20110201692-A1 | ANTIMICROBIAL FLUSH SOLUTIONS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-08-18 | — | — | US | claimed |
| US-20100055086-A1 | Antimicrobial Flush Solutions | RAAD ISSAM | 2010-03-04 | — | — | US | claimed |
| EP-1644024-A2 | ANTIMICROBIAL FLUSH SOLUTIONS | Board of Regents, The University of Texas System (US) | 2006-04-12 | — | — | EP | claimed |
| US-20050013836-A1 | Antimicrobial flush solutions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-01-20 | — | — | US | claimed |
| WO-2004108091-A2 | ANTIMICROBIAL FLUSH SOLUTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-12-16 | — | — | WO | claimed |
| US-6187768-B1 | DRY LYOPHILIZED UNIT DOSE OF ANTIMICROBIAL AGENT AND SECOND AGENT OF ANTICOAGULANT, ANTITHROMBOTIC AGENT AND/OR CHELATING AGENT | BECTON, DICKINSON AND COMPANY | 2001-02-13 | — | — | US | claimed |
| WO-2000072906-A1 | KIT FOR FLUSHING MEDICAL DEVICES AND METHOD OF PREPARING THE FLUSHING SOLUTION | BECTON, DICKINSON AND COMPANY (US) | 2000-12-07 | — | — | WO | claimed |
| US-5898077-A | Process for preparation of an ester | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 1999-04-27 | — | — | US | claimed |
| US-5760265-A | Process for preparation of an ester utilizing an esterifying catalyst | MATSUMOTO YUSHI SEIYAKU CO., LTD. (JP) | 1998-06-02 | — | — | US | claimed |
| US-5688516-A | Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-11-18 | — | — | US | claimed |
| WO-1995025195-A1 | TEXTILE BLEACHING PROCESS | SOLVAY INTEROX LIMITED (GB) | 1995-09-21 | — | — | WO | claimed |
| EP-0301477-A2 | Silver halide color photosensitive material and method of processing thereof | Fuji Photo Film Co., Ltd. (JP) | 1989-02-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231302-A1 | ANTIMICROBIAL SOLUTIONS | UGCG, GANAB, GANC | CYP1A2 4051/4885CYP2C9 4291/4885TSHR 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.